Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Potential Impact of the Medicare Prescription Payment Plan for Medicare Part D Beneficiaries With a Cancer Diagnosis.
Aryana Sepassi, Scott D Ramsey, A Mark Fendrick, Nico Gabriel, Jason A Zell, Dana B Mukamel, Sean D Sullivan
Published: 202610.1200/JCO-25-01788
Abstract
PURPOSE: To address high out-of-pocket (OOP) medication costs among Medicare Part D beneficiaries, the 2022 Inflation Reduction Act introduced the Medicare Prescription Payment Plan (M3P), a voluntary program that allows beneficiaries to spread OOP c…
Preview only. Read the full abstract at the source